Mitochondrial complex I deficiency in Parkinson's disease

AHV Schapira, JM Cooper, D Dexter… - Journal of …, 1990 - Wiley Online Library
AHV Schapira, JM Cooper, D Dexter, JB Clark, P Jenner, CD Marsden
Journal of neurochemistry, 1990Wiley Online Library
The structure and function of mitochondrial respiratory‐chain enzyme proteins were studied
postmortem in the substantia nigra of nine patients with Parkinson's disease and nine
matched controls. Total protein and mitochondrial mass were similar in the two groups.
NADH‐ubiquinone reductase (Complex I) and NADH cytochrome c reductase activities were
significantly reduced, whereas succinate cytochrome c reductase activity was normal. These
results indicated a specific defect of Complex I activity in the substantia nigra of patients with …
Abstract
The structure and function of mitochondrial respiratory‐chain enzyme proteins were studied postmortem in the substantia nigra of nine patients with Parkinson's disease and nine matched controls. Total protein and mitochondrial mass were similar in the two groups. NADH‐ubiquinone reductase (Complex I) and NADH cytochrome c reductase activities were significantly reduced, whereas succinate cytochrome c reductase activity was normal. These results indicated a specific defect of Complex I activity in the substantia nigra of patients with Parkinson's disease. This biochemical defect is the same as that produced in animal models of parkinsonism by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) and adds further support to the proposition that Parkinson's disease may be due to an environmental toxin with action(s) similar to those of MPTP.
Wiley Online Library